Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071331
Status:
COMPLETED
Last Update Posted:
2012-05-03
First Post:
2003-10-20
Brief Title:
EVEREST Efficacy of Vasopressin Antagonism in hEart failuRE Outcome Study With Tolvaptan
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2006-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-07
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-20
First Submit QC Date:
October 20 2003
Study First Post Date:
2003-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-02
Last Update Post Date:
2012-05-03
Last Update Post Date Type:
ESTIMATED